Fundraising Fox

iotaMotion

St. Paul, US · Delaware corporation · 3 known investors

iotamotion.com

iotaMotion develops robotic systems for cochlear implant surgery, assisting otolaryngologists in achieving precision beyond human capability. The company serves surgical teams performing cochlear implant procedures and is headquartered in the United States.

HealthtechMedical DevicesRobotics

Founders & leadership

MH
Marlan Hansen, MDCo-founder
MHMarlan Hansen
Marlan HansenCo-founder
CK
Christopher KaufmannCo-founder
ML
Michael LobinskyExecutive

Board

WWWayne Wallace
Wayne WallaceBoard directorCo-founder at Mutual Capital Partners
MC
Michael CrookBoard director
CM
Christopher MartinBoard director
EBEric B. Timko
Eric B. TimkoBoard director

Investors · 3

Reported raises · per SEC filings

Form D private placements

$23.4M disclosed across 7 rounds · 2017–2026

$1.9MraisedMar 2026 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Vinnie BellanteExecutive Officer
  • Eric B. TimkoDirector
  • Jeff HopkinsDirector
  • Michael LobinskyExecutive Officer, Director
  • Marie CalabriaExecutive Officer
  • Marlan Hansen, MDExecutive Officer, Director
  • Costa NikouExecutive Officer
  • Mike BushlackExecutive Officer
  • Michael CrookDirector
  • Wayne WallaceDirector
  • Christopher MartinDirector
Offering amount
$10M
Amount sold
$1.9M
First sale
Feb 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6.4MraisedJan 2025 · 25 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael LobinskyExecutive Officer, Director
  • Christopher MartinDirector
  • Marlan Hansen, MDExecutive Officer, Director
  • Wayne WallaceDirector
  • Michael CrookDirector
  • Eric B. TimkoDirector
Offering amount
$15M
Amount sold
$6.4M
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$8.5MraisedApr 2023 · 56 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael LobinskyExecutive Officer, Director
  • Marlan Hansen, MDExecutive Officer, Director
  • Eric B. TimkoDirector
Offering amount
$15M
Amount sold
$8.5M
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.1MraisedMar 2023 · 47 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric B. TimkoDirector
  • Marlan Hansen, MDExecutive Officer, Director
  • Michael LobinskyExecutive Officer, Director
  • Christopher Kaufmann, MD MSDirector
Offering amount
$3.1M
Amount sold
$3.1M
Proceeds to insiders
$187.5K
First sale
Jan 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.2MraisedApr 2021 · 32 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Marlan HansenExecutive Officer, Director
  • Christopher KaufmannExecutive Officer, Director
  • Eric B. TimkoDirector
Offering amount
$1.2M
Amount sold
$1.2M
Proceeds to insiders
$187.5K
First sale
Feb 2021
Incorporated
Corporation, De
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$100KraisedApr 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher Kaufmann, MD MSExecutive Officer, Director
  • Eric B. TimkoExecutive Officer, Director
  • Marlan Hansen, MDExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$100K
Proceeds to insiders
$210.5K
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.1MraisedOct 2018 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Marlan Hansen, MDExecutive Officer, Director
  • Eric B. TimkoDirector
  • Christopher Kaufmann, MD MSExecutive Officer, Director
Offering amount
$2.2M
Amount sold
$2.1M
Minimum investment
$50K
Proceeds to insiders
$230K
First sale
May 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with iotaMotion for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 4 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$225K
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$1.5M
National Science FoundationPhase I2016$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does iotaMotion do?
iotaMotion develops robotic systems for cochlear implant surgery, assisting otolaryngologists in achieving precision beyond human capability. The company serves surgical teams performing cochlear implant procedures and is headquartered in the United States.
Who founded iotaMotion?
iotaMotion was founded by Marlan Hansen, MD, Marlan Hansen, Christopher Kaufmann.
Who are iotaMotion's investors?
iotaMotion's investors include ISA Ventures, Mutual Capital Partners, Next Level Ventures.
How much funding has iotaMotion raised?
iotaMotion has disclosed $23.4M raised across 7 rounds.
Where is iotaMotion headquartered?
iotaMotion is headquartered in St. Paul, US.